Mapping the Pareto optimal design space for a functionally deimmunized biotherapeutic candidate.

The immunogenicity of biotherapeutics can bottleneck development pipelines and poses a barrier to widespread clinical application. As a result, there is a growing need for improved deimmunization technologies. We have recently described algorithms that simultaneously optimize proteins for both reduc...

Full description

Bibliographic Details
Main Authors: Regina S Salvat, Andrew S Parker, Yoonjoo Choi, Chris Bailey-Kellogg, Karl E Griswold
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS Computational Biology
Online Access:http://europepmc.org/articles/PMC4288714?pdf=render